Author

Karl W. Lauterbach

Observed names: K Lauterbach, K W Lauterbach, K. Lauterbach, K. W. Lauterbach, K. Lauterbach, K.W Lauterbach, K.W. Lauterbach, KW Lauterbach, Karl Lauterbach, Karl W Lauterbach, Karl Wilhelm Lauterbach, Karl Wilhelm Lauterbach, Lauterbach, Karl, Lauterbach, Karl W.

Institution: Harvard University

Observed institutions: Harvard University, University of Cologne, Institute of Health Economics, Federal Government of Germany, University Hospital Cologne, Federal Ministry of Health

OpenAlex ID: A5025752482

Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL Study

2002 · Axel Schmermund, Stefan Möhlenkamp, et al. · American Heart Journal · 582

Diagnosis and treatment of diverticular disease

1999 · L. Köhler, S. Sauerland, et al. · Surgical Endoscopy · 473

Health Services Research

1998 · J. I. Williams, J. Höher, et al. · Springer eBooks · 411

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany

2008 · Markus Lungen, Bjoern Stollenwerk, et al. · International Journal for Equity in Health · 190

PDF

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results

2000 · Markus Dietlein, Kerstin Weber, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 138

German Diabetes Management Programs Improve Quality Of Care And Curb Costs

2010 · Stephanie Stock, Anna Drabik, et al. · Health Affairs · 130

Asthma: prevalence and cost of illness

2005 · S. Stock, M. Redaelli, et al. · European Respiratory Journal · 123

PDF

Threshold Volumes Associated With Higher Survival in Health Care

2003 · Afschin Gandjour, Angelika Bannenberg, et al. · Medical Care · 109

Management Patterns and Health Care Use after Intracerebral Hemorrhage

2003 · Christian Weimar, Carsten Weber, et al. · Cerebrovascular Diseases · 96

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany

2000 · Markus Dietlein, Kerstin Weber, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 73

Weight Reduction by Sibutramine in Obese Subjects in Primary Care Medicine: The S. A. T. Study

2004 · H. Hauner, M. Meier, et al. · Experimental and Clinical Endocrinology & Diabetes · 71

Noncoronary Measures Enhance the Predictive Value of Cardiac CT Above Traditional Risk Factors and CAC Score in the General Population

2016 · Amir A. Mahabadi, Nils Lehmann, et al. · JACC. Cardiovascular imaging · 67

Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation

2000 · K. Bestehorn, M. Biller, et al. · Medizinische Klinik - Intensivmedizin und Notfallmedizin · 64

Diabetes—prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany

2005 · S. A. K. Stock, M. Redaelli, et al. · Diabetic Medicine · 63

PDF

Does prevention save costs?

2005 · Afschin Gandjour, Karl Wilhelm Lauterbach · Journal of Health Economics · 60

Gesundheitsversorgung und Disease Management – Grundlagen und Anwendungen der Versorgungsforschung

2004 · Holger Pfaff, Matthias Schrappe, et al. · Pflege · 53

Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease

2021 · Janine Gronewold, Miriam Engels, et al. · Stroke · 50

PDF

Ankle–brachial index predicts stroke in the general population in addition to classical risk factors

2014 · Janine Gronewold, Dirk M. Hermann, et al. · Atherosclerosis · 42

PDF

Review of Quality-of-Life Evaluations in Patients with Angina Pectoris

1999 · Afschin Gandjour, Karl W. Lauterbach · PharmacoEconomics · 42

Sex Differences in Treatment Patterns of Six Chronic Diseases: An Analysis from the German Statutory Health Insurance

2008 · Stephanie A.K. Stock, Björn Stollenwerk, et al. · Journal of Women s Health · 40

An Evidence-Based Evaluation of Quality and Efficiency Indicators

2002 · Afschin Gandjour, Frauke Kleinschmit, et al. · Quality Management in Health Care · 39

Utilitarian Theories Reconsidered: Common Misconceptions, More Recent Developments, and Health Policy Implications

2003 · Afschin Gandjour, Karl Wilhelm Lauterbach · Health Care Analysis · 38

Community pandemic response: the importance of action led by communities and the public sector

2022 · Winnie Byanyima, Karl Lauterbach, et al. · The Lancet · 36

PDF

Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.

1998 · C J Troche, J Tacke, et al. · PubMed · 35

Disease management and health care reforms in Germany—Does more competition lead to less solidarity?

2006 · Stephanie Anja Katharina Stock, Marcus Redaelli, et al. · Health Policy · 33

Works count: 192

Citation count: 4,010

H-index: 29

I10-index: 62